nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergonovine—ABCB1—melanoma	0.537	1	CbGaD
Ergonovine—CYP3A4—Temozolomide—melanoma	0.133	0.376	CbGbCtD
Ergonovine—ABCB1—Dactinomycin—melanoma	0.0809	0.229	CbGbCtD
Ergonovine—CYP3A4—Vemurafenib—melanoma	0.0729	0.206	CbGbCtD
Ergonovine—ABCB1—Docetaxel—melanoma	0.0418	0.118	CbGbCtD
Ergonovine—CYP3A4—Docetaxel—melanoma	0.025	0.0708	CbGbCtD
Ergonovine—Vasospasm—Carmustine—melanoma	0.00102	0.107	CcSEcCtD
Ergonovine—Drug interaction—Carmustine—melanoma	0.000375	0.0394	CcSEcCtD
Ergonovine—Thrombophlebitis—Carmustine—melanoma	0.000292	0.0307	CcSEcCtD
Ergonovine—Thrombophlebitis—Temozolomide—melanoma	0.000282	0.0297	CcSEcCtD
Ergonovine—Nasal congestion—Temozolomide—melanoma	0.000268	0.0282	CcSEcCtD
Ergonovine—Drug interaction—Docetaxel—melanoma	0.000241	0.0254	CcSEcCtD
Ergonovine—Acute coronary syndrome—Bleomycin—melanoma	0.00022	0.0231	CcSEcCtD
Ergonovine—Hypotension—Vemurafenib—melanoma	0.000219	0.0231	CcSEcCtD
Ergonovine—Myocardial infarction—Bleomycin—melanoma	0.000219	0.023	CcSEcCtD
Ergonovine—Haematuria—Bleomycin—melanoma	0.000213	0.0224	CcSEcCtD
Ergonovine—Pulmonary oedema—Docetaxel—melanoma	0.000199	0.0209	CcSEcCtD
Ergonovine—Thrombophlebitis—Docetaxel—melanoma	0.000187	0.0197	CcSEcCtD
Ergonovine—Hallucination—Carmustine—melanoma	0.000174	0.0183	CcSEcCtD
Ergonovine—Hallucination—Temozolomide—melanoma	0.000168	0.0177	CcSEcCtD
Ergonovine—Diarrhoea—Vemurafenib—melanoma	0.000161	0.0169	CcSEcCtD
Ergonovine—Tinnitus—Temozolomide—melanoma	0.000157	0.0166	CcSEcCtD
Ergonovine—Dizziness—Vemurafenib—melanoma	0.000155	0.0163	CcSEcCtD
Ergonovine—Vomiting—Vemurafenib—melanoma	0.000149	0.0157	CcSEcCtD
Ergonovine—Chest pain—Bleomycin—melanoma	0.000148	0.0156	CcSEcCtD
Ergonovine—Headache—Vemurafenib—melanoma	0.000147	0.0155	CcSEcCtD
Ergonovine—Nausea—Vemurafenib—melanoma	0.000139	0.0147	CcSEcCtD
Ergonovine—Hypotension—Bleomycin—melanoma	0.000133	0.014	CcSEcCtD
Ergonovine—Vertigo—Temozolomide—melanoma	0.000132	0.0139	CcSEcCtD
Ergonovine—Hypertension—Carmustine—melanoma	0.000131	0.0138	CcSEcCtD
Ergonovine—Palpitations—Temozolomide—melanoma	0.00013	0.0137	CcSEcCtD
Ergonovine—Chest pain—Carmustine—melanoma	0.000129	0.0136	CcSEcCtD
Ergonovine—Hypertension—Temozolomide—melanoma	0.000127	0.0133	CcSEcCtD
Ergonovine—Dyspnoea—Bleomycin—melanoma	0.000127	0.0133	CcSEcCtD
Ergonovine—Acute coronary syndrome—Docetaxel—melanoma	0.000123	0.013	CcSEcCtD
Ergonovine—Myocardial infarction—Docetaxel—melanoma	0.000123	0.0129	CcSEcCtD
Ergonovine—Hypotension—Carmustine—melanoma	0.000116	0.0122	CcSEcCtD
Ergonovine—Hyperhidrosis—Temozolomide—melanoma	0.000116	0.0122	CcSEcCtD
Ergonovine—Dyspnoea—Carmustine—melanoma	0.000111	0.0116	CcSEcCtD
Ergonovine—Gastrointestinal pain—Dactinomycin—melanoma	0.000108	0.0114	CcSEcCtD
Ergonovine—Dyspnoea—Temozolomide—melanoma	0.000107	0.0112	CcSEcCtD
Ergonovine—Abdominal pain—Dactinomycin—melanoma	0.000105	0.011	CcSEcCtD
Ergonovine—Gastrointestinal pain—Carmustine—melanoma	0.000101	0.0107	CcSEcCtD
Ergonovine—Abdominal pain—Carmustine—melanoma	9.81e-05	0.0103	CcSEcCtD
Ergonovine—Gastrointestinal pain—Temozolomide—melanoma	9.81e-05	0.0103	CcSEcCtD
Ergonovine—Abdominal pain—Temozolomide—melanoma	9.48e-05	0.00997	CcSEcCtD
Ergonovine—Muscle spasms—Docetaxel—melanoma	9.4e-05	0.00988	CcSEcCtD
Ergonovine—Diarrhoea—Dactinomycin—melanoma	9.07e-05	0.00954	CcSEcCtD
Ergonovine—Vomiting—Bleomycin—melanoma	9.04e-05	0.00951	CcSEcCtD
Ergonovine—Palpitations—Docetaxel—melanoma	8.64e-05	0.00908	CcSEcCtD
Ergonovine—Diarrhoea—Carmustine—melanoma	8.49e-05	0.00893	CcSEcCtD
Ergonovine—Nausea—Bleomycin—melanoma	8.45e-05	0.00888	CcSEcCtD
Ergonovine—Hypertension—Docetaxel—melanoma	8.44e-05	0.00888	CcSEcCtD
Ergonovine—Vomiting—Dactinomycin—melanoma	8.43e-05	0.00887	CcSEcCtD
Ergonovine—Chest pain—Docetaxel—melanoma	8.32e-05	0.00875	CcSEcCtD
Ergonovine—Dizziness—Carmustine—melanoma	8.21e-05	0.00863	CcSEcCtD
Ergonovine—Diarrhoea—Temozolomide—melanoma	8.21e-05	0.00863	CcSEcCtD
Ergonovine—Dizziness—Temozolomide—melanoma	7.93e-05	0.00834	CcSEcCtD
Ergonovine—Vomiting—Carmustine—melanoma	7.89e-05	0.0083	CcSEcCtD
Ergonovine—Nausea—Dactinomycin—melanoma	7.88e-05	0.00829	CcSEcCtD
Ergonovine—Shock—Docetaxel—melanoma	7.85e-05	0.00825	CcSEcCtD
Ergonovine—Headache—Carmustine—melanoma	7.78e-05	0.00818	CcSEcCtD
Ergonovine—Vomiting—Temozolomide—melanoma	7.63e-05	0.00802	CcSEcCtD
Ergonovine—Headache—Temozolomide—melanoma	7.51e-05	0.0079	CcSEcCtD
Ergonovine—Hypotension—Docetaxel—melanoma	7.45e-05	0.00784	CcSEcCtD
Ergonovine—Nausea—Carmustine—melanoma	7.37e-05	0.00775	CcSEcCtD
Ergonovine—Nausea—Temozolomide—melanoma	7.12e-05	0.00749	CcSEcCtD
Ergonovine—Dyspnoea—Docetaxel—melanoma	7.11e-05	0.00748	CcSEcCtD
Ergonovine—Gastrointestinal pain—Docetaxel—melanoma	6.52e-05	0.00686	CcSEcCtD
Ergonovine—Abdominal pain—Docetaxel—melanoma	6.31e-05	0.00663	CcSEcCtD
Ergonovine—Diarrhoea—Docetaxel—melanoma	5.46e-05	0.00574	CcSEcCtD
Ergonovine—Dizziness—Docetaxel—melanoma	5.27e-05	0.00555	CcSEcCtD
Ergonovine—Vomiting—Docetaxel—melanoma	5.07e-05	0.00533	CcSEcCtD
Ergonovine—Headache—Docetaxel—melanoma	5e-05	0.00526	CcSEcCtD
Ergonovine—Nausea—Docetaxel—melanoma	4.74e-05	0.00498	CcSEcCtD
Ergonovine—HTR2C—Signaling Pathways—AKT3—melanoma	2.7e-05	0.000271	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—GAB2—melanoma	2.68e-05	0.000269	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—GNA11—melanoma	2.68e-05	0.000269	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—SLC6A11—melanoma	2.67e-05	0.000268	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PIP4K2A—melanoma	2.67e-05	0.000268	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—FLT1—melanoma	2.66e-05	0.000268	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	2.64e-05	0.000266	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—PIK3CG—melanoma	2.64e-05	0.000265	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—PIK3CA—melanoma	2.62e-05	0.000263	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—MDM2—melanoma	2.61e-05	0.000262	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—MTAP—melanoma	2.59e-05	0.000261	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—VCAN—melanoma	2.58e-05	0.000259	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—ERBB2—melanoma	2.57e-05	0.000258	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—PIK3CB—melanoma	2.54e-05	0.000255	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—HDAC2—melanoma	2.52e-05	0.000253	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—FOXO4—melanoma	2.52e-05	0.000253	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CXCR4—melanoma	2.52e-05	0.000253	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—SOCS1—melanoma	2.5e-05	0.000251	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—MAP2K1—melanoma	2.49e-05	0.000251	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—S100B—melanoma	2.49e-05	0.000251	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—GNAQ—melanoma	2.49e-05	0.00025	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—PIK3CD—melanoma	2.48e-05	0.000249	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CXCL8—melanoma	2.44e-05	0.000245	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—HRAS—melanoma	2.42e-05	0.000243	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—PIK3CG—melanoma	2.4e-05	0.000241	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—ERBB4—melanoma	2.39e-05	0.00024	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CDKN1B—melanoma	2.38e-05	0.000239	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—PIK3CB—melanoma	2.38e-05	0.000239	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CDKN2B—melanoma	2.36e-05	0.000238	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—AKT1—melanoma	2.35e-05	0.000237	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—SYK—melanoma	2.34e-05	0.000235	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CASP3—melanoma	2.33e-05	0.000235	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—IL2—melanoma	2.33e-05	0.000234	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—PIK3CD—melanoma	2.32e-05	0.000233	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—IL6—melanoma	2.32e-05	0.000233	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—LUM—melanoma	2.31e-05	0.000232	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PHGDH—melanoma	2.31e-05	0.000232	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—ITGAV—melanoma	2.3e-05	0.000231	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—AKT3—melanoma	2.3e-05	0.000231	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—NGFR—melanoma	2.3e-05	0.000231	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CD86—melanoma	2.29e-05	0.00023	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—CXCL8—melanoma	2.29e-05	0.00023	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CCND1—melanoma	2.27e-05	0.000228	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—EDN1—melanoma	2.27e-05	0.000228	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—HPSE—melanoma	2.27e-05	0.000228	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CTNNB1—melanoma	2.25e-05	0.000226	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	2.23e-05	0.000224	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CUBN—melanoma	2.23e-05	0.000224	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CSF2—melanoma	2.22e-05	0.000223	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—FGF1—melanoma	2.22e-05	0.000223	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—MMP9—melanoma	2.2e-05	0.000222	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CDKN1A—melanoma	2.2e-05	0.000221	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—PTEN—melanoma	2.19e-05	0.00022	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—IL2—melanoma	2.18e-05	0.00022	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—NFKB1—melanoma	2.18e-05	0.000219	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CYP17A1—melanoma	2.18e-05	0.000219	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—E2F1—melanoma	2.17e-05	0.000218	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—PIK3CB—melanoma	2.16e-05	0.000217	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—SDHD—melanoma	2.15e-05	0.000216	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—BSG—melanoma	2.15e-05	0.000216	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CSPG4—melanoma	2.15e-05	0.000216	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PDGFRA—melanoma	2.15e-05	0.000216	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—AKT1—melanoma	2.14e-05	0.000215	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—ITGB3—melanoma	2.13e-05	0.000214	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—SOCS1—melanoma	2.13e-05	0.000214	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PRKCA—melanoma	2.13e-05	0.000214	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—MAP2K1—melanoma	2.12e-05	0.000213	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—S100B—melanoma	2.12e-05	0.000213	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—PIK3CD—melanoma	2.11e-05	0.000212	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—SPP1—melanoma	2.08e-05	0.00021	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GPAM—melanoma	2.08e-05	0.000209	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MAP2K2—melanoma	2.08e-05	0.000209	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—CXCL8—melanoma	2.08e-05	0.000209	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—GNA11—melanoma	2.06e-05	0.000207	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—ERBB4—melanoma	2.03e-05	0.000204	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—PIK3CB—melanoma	2.02e-05	0.000203	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	2.02e-05	0.000203	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—FASN—melanoma	2.01e-05	0.000202	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CDKN2B—melanoma	2.01e-05	0.000202	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—IL2—melanoma	1.98e-05	0.000199	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—VEGFA—melanoma	1.98e-05	0.000199	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—SLC5A5—melanoma	1.98e-05	0.000199	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—TERT—melanoma	1.98e-05	0.000199	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—RAC1—melanoma	1.97e-05	0.000198	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—STAT3—melanoma	1.96e-05	0.000197	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—NRAS—melanoma	1.96e-05	0.000197	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CD86—melanoma	1.94e-05	0.000195	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—CXCL8—melanoma	1.94e-05	0.000195	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—EDN1—melanoma	1.93e-05	0.000194	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—GNAQ—melanoma	1.91e-05	0.000192	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CD44—melanoma	1.91e-05	0.000192	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—HIF1A—melanoma	1.89e-05	0.00019	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—FGF1—melanoma	1.89e-05	0.00019	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CSF2—melanoma	1.89e-05	0.00019	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—MAPK3—melanoma	1.87e-05	0.000188	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—IL2—melanoma	1.86e-05	0.000187	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—E2F1—melanoma	1.85e-05	0.000185	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—PIK3CB—melanoma	1.84e-05	0.000185	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CYP1B1—melanoma	1.83e-05	0.000184	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PDGFRA—melanoma	1.83e-05	0.000184	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—MYC—melanoma	1.82e-05	0.000183	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PRKCA—melanoma	1.81e-05	0.000182	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—ITGB3—melanoma	1.81e-05	0.000182	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—KDR—melanoma	1.81e-05	0.000182	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—MAPK1—melanoma	1.78e-05	0.000179	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—EGFR—melanoma	1.78e-05	0.000179	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—SPP1—melanoma	1.77e-05	0.000178	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PLA2G6—melanoma	1.77e-05	0.000178	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MAP2K2—melanoma	1.77e-05	0.000178	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—CXCL8—melanoma	1.76e-05	0.000177	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—FN1—melanoma	1.74e-05	0.000175	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—NOTCH1—melanoma	1.7e-05	0.000171	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—IL2—melanoma	1.69e-05	0.00017	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—KRAS—melanoma	1.68e-05	0.000169	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—TERT—melanoma	1.68e-05	0.000169	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—RAC1—melanoma	1.68e-05	0.000168	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CD80—melanoma	1.67e-05	0.000168	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—KIT—melanoma	1.67e-05	0.000167	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—APC—melanoma	1.67e-05	0.000167	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PIK3CG—melanoma	1.67e-05	0.000167	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—NRAS—melanoma	1.67e-05	0.000167	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—EGF—melanoma	1.65e-05	0.000165	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—HIF1A—melanoma	1.61e-05	0.000162	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—MAPK3—melanoma	1.59e-05	0.00016	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—VCAN—melanoma	1.59e-05	0.00016	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—BRAF—melanoma	1.57e-05	0.000157	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—PIK3CA—melanoma	1.55e-05	0.000155	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—KDR—melanoma	1.54e-05	0.000155	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IGF1—melanoma	1.52e-05	0.000153	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—MAPK1—melanoma	1.52e-05	0.000153	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—EGFR—melanoma	1.52e-05	0.000153	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—TP53—melanoma	1.5e-05	0.00015	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—FN1—melanoma	1.48e-05	0.000149	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MAP2K1—melanoma	1.47e-05	0.000148	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PIK3CD—melanoma	1.46e-05	0.000147	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—PIK3CA—melanoma	1.45e-05	0.000146	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—NOTCH1—melanoma	1.45e-05	0.000146	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—KRAS—melanoma	1.43e-05	0.000144	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—HRAS—melanoma	1.43e-05	0.000144	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CD80—melanoma	1.42e-05	0.000143	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—APC—melanoma	1.42e-05	0.000142	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PIK3CG—melanoma	1.42e-05	0.000142	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—KIT—melanoma	1.42e-05	0.000142	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—NRAS—melanoma	1.42e-05	0.000142	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—FGF2—melanoma	1.4e-05	0.000141	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—EGF—melanoma	1.4e-05	0.000141	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PRKCA—melanoma	1.39e-05	0.00014	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—ERCC2—melanoma	1.38e-05	0.000138	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—IL6—melanoma	1.37e-05	0.000138	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—MAPK3—melanoma	1.36e-05	0.000136	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CYP17A1—melanoma	1.34e-05	0.000135	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—BRAF—melanoma	1.33e-05	0.000134	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—PIK3CA—melanoma	1.32e-05	0.000132	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MDM2—melanoma	1.31e-05	0.000132	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IGF1—melanoma	1.3e-05	0.00013	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—ERBB2—melanoma	1.29e-05	0.00013	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—MAPK1—melanoma	1.29e-05	0.00013	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—EGFR—melanoma	1.29e-05	0.00013	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PIK3CB—melanoma	1.28e-05	0.000128	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GNA11—melanoma	1.27e-05	0.000127	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—AKT1—melanoma	1.26e-05	0.000127	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MAP2K1—melanoma	1.25e-05	0.000126	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PIK3CD—melanoma	1.24e-05	0.000125	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—FASN—melanoma	1.24e-05	0.000125	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—PIK3CA—melanoma	1.23e-05	0.000124	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CXCL8—melanoma	1.23e-05	0.000123	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—SLC5A5—melanoma	1.22e-05	0.000123	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—KRAS—melanoma	1.22e-05	0.000122	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—HRAS—melanoma	1.22e-05	0.000122	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CDKN1B—melanoma	1.2e-05	0.00012	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—FGF2—melanoma	1.19e-05	0.00012	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—AKT1—melanoma	1.18e-05	0.000119	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GNAQ—melanoma	1.18e-05	0.000118	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CD44—melanoma	1.18e-05	0.000118	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CASP3—melanoma	1.17e-05	0.000118	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IL2—melanoma	1.17e-05	0.000118	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—IL6—melanoma	1.17e-05	0.000117	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CCND1—melanoma	1.14e-05	0.000115	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CTNNB1—melanoma	1.13e-05	0.000114	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CYP1B1—melanoma	1.13e-05	0.000114	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—PIK3CA—melanoma	1.12e-05	0.000113	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MDM2—melanoma	1.12e-05	0.000112	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MMP9—melanoma	1.11e-05	0.000111	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CDKN1A—melanoma	1.11e-05	0.000111	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PTEN—melanoma	1.1e-05	0.000111	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—ERBB2—melanoma	1.1e-05	0.000111	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—NFKB1—melanoma	1.1e-05	0.00011	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PIK3CG—melanoma	1.09e-05	0.000109	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PIK3CB—melanoma	1.08e-05	0.000109	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—AKT1—melanoma	1.08e-05	0.000108	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PPARG—melanoma	1.05e-05	0.000106	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CXCL8—melanoma	1.04e-05	0.000105	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—HRAS—melanoma	1.04e-05	0.000104	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CDKN1B—melanoma	1.02e-05	0.000102	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—AKT1—melanoma	1.01e-05	0.000101	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CASP3—melanoma	9.98e-06	0.0001	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IL2—melanoma	9.96e-06	0.0001	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—VEGFA—melanoma	9.96e-06	0.0001	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—IL6—melanoma	9.91e-06	9.97e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—STAT3—melanoma	9.86e-06	9.91e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—NRAS—melanoma	9.84e-06	9.89e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CCND1—melanoma	9.71e-06	9.76e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CTNNB1—melanoma	9.62e-06	9.67e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PIK3CD—melanoma	9.56e-06	9.61e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—ALB—melanoma	9.44e-06	9.49e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MMP9—melanoma	9.43e-06	9.48e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MAPK3—melanoma	9.42e-06	9.47e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CDKN1A—melanoma	9.4e-06	9.45e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PTEN—melanoma	9.37e-06	9.42e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—NFKB1—melanoma	9.33e-06	9.38e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ABCB1—melanoma	9.3e-06	9.35e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MYC—melanoma	9.16e-06	9.21e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—AKT1—melanoma	9.15e-06	9.19e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MAPK1—melanoma	8.96e-06	9.01e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—EGFR—melanoma	8.96e-06	9.01e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PRKCA—melanoma	8.56e-06	8.6e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ERCC2—melanoma	8.49e-06	8.53e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—VEGFA—melanoma	8.47e-06	8.51e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—KRAS—melanoma	8.47e-06	8.51e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—STAT3—melanoma	8.38e-06	8.43e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—NRAS—melanoma	8.36e-06	8.41e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PIK3CB—melanoma	8.34e-06	8.38e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PTGS2—melanoma	8.26e-06	8.3e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MAPK3—melanoma	8.01e-06	8.05e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MYC—melanoma	7.79e-06	7.83e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PIK3CA—melanoma	7.78e-06	7.82e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MAPK1—melanoma	7.62e-06	7.66e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—EGFR—melanoma	7.62e-06	7.66e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—TP53—melanoma	7.52e-06	7.56e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PTEN—melanoma	7.2e-06	7.24e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—KRAS—melanoma	7.2e-06	7.24e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—HRAS—melanoma	7.2e-06	7.23e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IL6—melanoma	6.89e-06	6.92e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PIK3CG—melanoma	6.7e-06	6.74e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PIK3CA—melanoma	6.61e-06	6.65e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PPARG—melanoma	6.47e-06	6.5e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—TP53—melanoma	6.4e-06	6.43e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—AKT1—melanoma	6.35e-06	6.39e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—HRAS—melanoma	6.12e-06	6.15e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PIK3CD—melanoma	5.89e-06	5.92e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IL6—melanoma	5.86e-06	5.89e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ALB—melanoma	5.82e-06	5.85e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—AKT1—melanoma	5.4e-06	5.43e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PIK3CB—melanoma	5.14e-06	5.16e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PTGS2—melanoma	5.09e-06	5.12e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PIK3CA—melanoma	5.08e-06	5.11e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PTEN—melanoma	4.44e-06	4.46e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—AKT1—melanoma	4.15e-06	4.17e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PIK3CA—melanoma	3.13e-06	3.15e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—AKT1—melanoma	2.56e-06	2.57e-05	CbGpPWpGaD
